[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

EMEA Drugs for Schistosomiasis Market by Manufacturers, Regions, Type and Application, Forecast to 2022

September 2017 | 120 pages | ID: E8E635454FBEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

Scope of the Report:

This report focuses on the Drugs for Schistosomiasis in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
  • Shin Poong
  • Merck
  • Bayer
  • EIPICO
  • Chandra Bhagat Pharma
  • Taj Pharmaceuticals
Market Segment by Regions, regional analysis covers
  • Europe (Germany, France, UK, Russia, Italy and Turkey)
  • Middle East (Saudi Arabia, Israel, UAE and Iran)
  • Africa (South Africa, Nigeria, Egypt and Algeria)
Market Segment by Type, covers
  • Praziquantel
  • Oxamniquine
  • Other
Market Segment by Applica tions, can be divided into
  • S. haematobium
  • S. mansoni
  • S. japonicum
  • S. mekongi
  • S. intercalatum
There are 13 Chapters to deeply display the EMEA Drugs for Schistosomiasis market.

Chapter 1, to describe Drugs for Schistosomiasis Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Drugs for Schistosomiasis, with sales, revenue, and price of Drugs for Schistosomiasis, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Drugs for Schistosomiasis, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Drugs for Schistosomiasis market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Drugs for Schistosomiasis research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source
1 MARKET OVERVIEW

1.1 Drugs for Schistosomiasis Introduction
1.2 Market Analysis by Type
  1.2.1 Praziquantel
  1.2.2 Oxamniquine
  1.2.3 Other
1.3 Market Analysis by Applications
  1.3.1 S. haematobium
  1.3.2 S. mansoni
  1.3.3 S. japonicum
  1.3.4 S. mekongi
  1.3.5 S. intercalatum
1.4 Market Analysis by Regions
  1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
    1.4.1.1 Germany Market States and Outlook (2012-2022)
    1.4.1.2 France Market States and Outlook (2012-2022)
    1.4.1.3 UK Market States and Outlook (2012-2022)
    1.4.1.4 Italy Market States and Outlook (2012-2022)
    1.4.1.5 Russia Market States and Outlook (2012-2022)
    1.4.1.6 Turkey Market States and Outlook (2012-2022)
  1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
    1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.2.2 UAE Market States and Outlook (2012-2022)
    1.4.2.3 Israel Market States and Outlook (2012-2022)
    1.4.2.4 Iran Market States and Outlook (2012-2022)
  1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
    1.4.3.1 South Africa Market States and Outlook (2012-2022)
    1.4.3.2 Nigeria Market States and Outlook (2012-2022)
    1.4.3.3 Egypt Market States and Outlook (2012-2022)
    1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Shin Poong
  2.1.1 Business Overview
  2.1.2 Drugs for Schistosomiasis Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
  2.2.1 Business Overview
  2.2.2 Drugs for Schistosomiasis Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
  2.3.1 Business Overview
  2.3.2 Drugs for Schistosomiasis Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 EIPICO
  2.4.1 Business Overview
  2.4.2 Drugs for Schistosomiasis Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Chandra Bhagat Pharma
  2.5.1 Business Overview
  2.5.2 Drugs for Schistosomiasis Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Taj Pharmaceuticals
  2.6.1 Business Overview
  2.6.2 Drugs for Schistosomiasis Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 EMEA DRUGS FOR SCHISTOSOMIASIS MARKET COMPETITION, BY MANUFACTURER

3.1 EMEA Drugs for Schistosomiasis Sales and Market Share by Manufacturer
3.2 EMEA Drugs for Schistosomiasis Revenue and Market Share by Manufacturer
3.3 EMEA Drugs for Schistosomiasis Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Drugs for Schistosomiasis Manufacturer Market Share
  3.4.2 Top 5 Drugs for Schistosomiasis Manufacturer Market Share
3.5 Market Competition Trend

4 EMEA DRUGS FOR SCHISTOSOMIASIS MARKET ANALYSIS BY REGIONS

4.1 EMEA Drugs for Schistosomiasis Sales, Revenue and Market Share by Regions
  4.1.1 EMEA Drugs for Schistosomiasis Sales by Regions (2012-2017)
  4.1.2 EMEA Drugs for Schistosomiasis Revenue by Regions (2012-2017)
4.2 Europe Drugs for Schistosomiasis Sales and Growth (2012-2017)
4.3 Middle East Drugs for Schistosomiasis Sales and Growth (2012-2017)
4.4 Africa Drugs for Schistosomiasis Sales and Growth (2012-2017)

5 EUROPE DRUGS FOR SCHISTOSOMIASIS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 Europe Drugs for Schistosomiasis Sales, Revenue and Market Share by Countries
  5.1.1 Europe Drugs for Schistosomiasis Sales by Countries (2012-2017)
  5.1.2 Europe Drugs for Schistosomiasis Revenue by Countries (2012-2017)
  5.1.3 Germany Drugs for Schistosomiasis Sales and Growth (2012-2017)
  5.1.4 France Drugs for Schistosomiasis Sales and Growth (2012-2017)
  5.1.5 UK Drugs for Schistosomiasis Sales and Growth (2012-2017)
  5.1.6 Russia Drugs for Schistosomiasis Sales and Growth (2012-2017)
  5.1.7 Italy Drugs for Schistosomiasis Sales and Growth (2012-2017)
  5.1.8 Turkey Drugs for Schistosomiasis Sales and Growth (2012-2017)
5.2 Europe Drugs for Schistosomiasis Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 Europe Drugs for Schistosomiasis Sales by Manufacturers (2016-2017)
  5.2.2 Europe Drugs for Schistosomiasis Revenue by Manufacturers (2016-2017)
5.3 Europe Drugs for Schistosomiasis Sales by Type (2012-2017)
5.4 Europe Drugs for Schistosomiasis Sales by Application (2012-2017)

6 MIDDLE EAST DRUGS FOR SCHISTOSOMIASIS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Middle East Drugs for Schistosomiasis Sales, Revenue and Market Share by Countries
  6.1.1 Middle East Drugs for Schistosomiasis Sales by Countries (2012-2017)
  6.1.2 Middle East Drugs for Schistosomiasis Revenue by Countries (2012-2017)
  6.1.3 Saudi Arabia Drugs for Schistosomiasis Sales and Growth (2012-2017)
  6.1.4 Israel Drugs for Schistosomiasis Sales and Growth (2012-2017)
  6.1.5 UAE Drugs for Schistosomiasis Sales and Growth (2012-2017)
  6.1.6 Iran Drugs for Schistosomiasis Sales and Growth (2012-2017)
6.2 Middle East Drugs for Schistosomiasis Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Middle East Drugs for Schistosomiasis Sales by Manufacturers (2016-2017)
  6.2.2 Middle East Drugs for Schistosomiasis Revenue by Manufacturers (2016-2017)
6.3 Middle East Drugs for Schistosomiasis Sales by Type (2012-2017)
6.4 Middle East Drugs for Schistosomiasis Sales by Application (2012-2017)

7 AFRICA DRUGS FOR SCHISTOSOMIASIS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Africa Drugs for Schistosomiasis Sales, Revenue and Market Share by Countries
  7.1.1 Africa Drugs for Schistosomiasis Sales by Countries (2012-2017)
  7.1.2 Africa Drugs for Schistosomiasis Revenue by Countries (2012-2017)
  7.1.3 South Africa Drugs for Schistosomiasis Sales and Growth (2012-2017)
  7.1.4 Nigeria Drugs for Schistosomiasis Sales and Growth (2012-2017)
  7.1.5 Egypt Drugs for Schistosomiasis Sales and Growth (2012-2017)
  7.1.6 Algeria Drugs for Schistosomiasis Sales and Growth (2012-2017)
7.2 Middle East Drugs for Schistosomiasis Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Middle East Drugs for Schistosomiasis Sales by Manufacturers (2016-2017)
  7.2.2 Middle East Drugs for Schistosomiasis Revenue by Manufacturers (2016-2017)
7.3 Middle East Drugs for Schistosomiasis Sales by Type (2012-2017)
7.4 Middle East Drugs for Schistosomiasis Sales by Application (2012-2017)

8 EMEA DRUGS FOR SCHISTOSOMIASIS MARKET SEGMENT BY TYPE

8.1 EMEA Drugs for Schistosomiasis Sales, Revenue and Market Share by Type (2012-2017)
  8.1.1 EMEA Drugs for Schistosomiasis Sales and Market Share by Type (2012-2017)
  8.1.2 EMEA Drugs for Schistosomiasis Revenue and Market Share by Type (2012-2017)
8.2 Praziquantel Sales Growth and Price
  10.2.1 EMEA Praziquantel Sales Growth (2012-2017)
  10.2.2 EMEA Praziquantel Price (2012-2017)
8.3 Oxamniquine Sales Growth and Price
  10.3.1 EMEA Oxamniquine Sales Growth (2012-2017)
  10.3.2 EMEA Oxamniquine Price (2012-2017)
8.4 Other Sales Growth and Price
  10.4.1 EMEA Other Sales Growth (2012-2017)
  10.4.2 EMEA Other Price (2012-2017)

9 EMEA DRUGS FOR SCHISTOSOMIASIS MARKET SEGMENT BY APPLICATION

9.1 EMEA Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
9.2 S. haematobium Sales Growth (2012-2017)
9.3 S. mansoni Sales Growth (2012-2017)
9.4 S. japonicum Sales Growth (2012-2017)
9.5 S. mekongi Sales Growth (2012-2017)
9.6 S. intercalatum Sales Growth (2012-2017)

10 EMEA DRUGS FOR SCHISTOSOMIASIS MARKET FORECAST (2017-2022)

10.1 EMEA Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2017-2022)
10.2 Drugs for Schistosomiasis Market Forecast by Regions (2017-2022)
  10.2.1 Europe Drugs for Schistosomiasis Market Forecast by Regions (2017-2022)
    10.2.1.1 Germany Drugs for Schistosomiasis Sales Forecast 2017-2022
    10.2.1.2 France Drugs for Schistosomiasis Sales Forecast 2017-2022
    10.2.1.3 UK Drugs for Schistosomiasis Sales Forecast 2017-2022
    10.2.1.4 Russia Drugs for Schistosomiasis Sales Forecast 2017-2022
    10.2.1.5 Italy Drugs for Schistosomiasis Sales Forecast 2017-2022
    10.2.1.6 Turkey Drugs for Schistosomiasis Sales Forecast 2017-2022
  10.2.2 Middle East Market Forecast by Regions (2017-2022)
    10.2.2.1 Saudi Arabia Drugs for Schistosomiasis Sales Forecast 2017-2022
    10.2.2.2 Israel Drugs for Schistosomiasis Sales Forecast 2017-2022
    10.2.2.3 UAE Drugs for Schistosomiasis Sales Forecast 2017-2022
    10.2.2.4 Iran Drugs for Schistosomiasis Sales Forecast 2017-2022
  10.2.3 Africa Market Forecast by Regions (2017-2022)
    10.2.3.1 South Africa Drugs for Schistosomiasis Sales Forecast 2017-2022
    10.2.3.2 Nigeria Drugs for Schistosomiasis Sales Forecast 2017-2022
    10.2.3.3 Egypt Drugs for Schistosomiasis Sales Forecast 2017-2022
    10.2.3.4 Algeria Drugs for Schistosomiasis Sales Forecast 2017-2022
10.3 Drugs for Schistosomiasis Market Forecast by Type (2017-2022)
10.4 Drugs for Schistosomiasis Market Forecast by Application (2017-2022)

11 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

11.1 Sales Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source
LIST OF TABLES AND FIGURES

Figure Drugs for Schistosomiasis Picture
Table Product Specifications of Drugs for Schistosomiasis
Figure EMEA Sales Market Share of Drugs for Schistosomiasis by Types in 2016
Table Drugs for Schistosomiasis Types for Major Manufacturers
Figure Praziquantel Picture
Figure Oxamniquine Picture
Figure Other Picture
Table Drugs for Schistosomiasis Sales Market Share by Applications in 2016
Figure S. haematobium Picture
Figure S. mansoni Picture
Figure S. japonicum Picture
Figure S. mekongi Picture
Figure S. intercalatum Picture
Figure Germany Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure France Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure UK Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2012-2022)
Table Shin Poong Basic Information, Manufacturing Base and Competitors
Table Shin Poong Drugs for Schistosomiasis Type and Applications
Table Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Drugs for Schistosomiasis Type and Applications
Table Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Drugs for Schistosomiasis Type and Applications
Table Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EIPICO Basic Information, Manufacturing Base and Competitors
Table EIPICO Drugs for Schistosomiasis Type and Applications
Table EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Type and Applications
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taj Pharmaceuticals Drugs for Schistosomiasis Type and Applications
Table Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure EMEA Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure EMEA Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table EMEA Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure EMEA Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Figure EMEA Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017
Table EMEA Drugs for Schistosomiasis Price by Manufacturer (2016-2017)
Figure EMEA Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure EMEA Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Table EMEA Drugs for Schistosomiasis Sales by Regions (2012-2017)
Table EMEA Drugs for Schistosomiasis Sales Market Share by Regions (2012-2017)
Figure EMEA Drugs for Schistosomiasis Sales Market Share by Regions in 2012
Figure EMEA Drugs for Schistosomiasis Sales Market Share by Regions in 2016
Table EMEA Drugs for Schistosomiasis Revenue by Regions (2012-2017)
Table EMEA Drugs for Schistosomiasis Revenue Market Share by Regions (2012-2017)
Figure EMEA Drugs for Schistosomiasis Revenue Market Share by Regions in 2012
Figure EMEA Drugs for Schistosomiasis Revenue Market Share by Regions in 2016
Figure Europe Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure Middle East Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure Africa Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure Europe Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Table Europe Drugs for Schistosomiasis Sales by Countries (2012-2017)
Table Europe Drugs for Schistosomiasis Sales Market Share by Countries (2012-2017)
Figure Europe Drugs for Schistosomiasis Sales Market Share by Countries in 2012
Figure Europe Drugs for Schistosomiasis Sales Market Share by Countries in 2016
Table Europe Drugs for Schistosomiasis Revenue by Countries (2012-2017)
Table Europe Drugs for Schistosomiasis Revenue Market Share by Countries (2012-2017)
Figure Europe Drugs for Schistosomiasis Revenue Market Share by Countries in 2012
Figure Europe Drugs for Schistosomiasis Revenue Market Share by Countries in 2016
Figure Germany Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure France Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure UK Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure Russia Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure Italy Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure Turkey Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Europe Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure Europe Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure Europe Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table Europe Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure Europe Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Figure Europe Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017
Table Europe Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Europe Drugs for Schistosomiasis Sales Share by Type (2012-2017)
Table Europe Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Europe Drugs for Schistosomiasis Sales Share by Application (2012-2017)
Figure Middle East Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Table Middle East Drugs for Schistosomiasis Sales by Countries (2012-2017)
Table Middle East Drugs for Schistosomiasis Sales Market Share by Countries (2012-2017)
Figure Middle East Drugs for Schistosomiasis Sales Market Share by Countries in 2012
Figure Middle East Drugs for Schistosomiasis Sales Market Share by Countries in 2016
Table Middle East Drugs for Schistosomiasis Revenue by Countries (2012-2017)
Table Middle East Drugs for Schistosomiasis Revenue Market Share by Countries (2012-2017)
Figure Middle East Drugs for Schistosomiasis Revenue Market Share by Countries in 2012
Figure Middle East Drugs for Schistosomiasis Revenue Market Share by Countries in 2016
Figure Saudi Arabia Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure Israel Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure UAE Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure Iran Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Middle East Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure Middle East Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure Middle East Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table Middle East Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure Middle East Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Figure Middle East Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017
Table Middle East Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Middle East Drugs for Schistosomiasis Sales Share by Type (2012-2017)
Table Middle East Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Middle East Drugs for Schistosomiasis Sales Share by Application (2012-2017)
Figure Africa Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Table Africa Drugs for Schistosomiasis Sales by Countries (2012-2017)
Table Africa Drugs for Schistosomiasis Sales Market Share by Countries (2012-2017)
Figure Africa Drugs for Schistosomiasis Sales Market Share by Countries in 2012
Figure Africa Drugs for Schistosomiasis Sales Market Share by Countries in 2016
Table Africa Drugs for Schistosomiasis Revenue by Countries (2012-2017)
Table Africa Drugs for Schistosomiasis Revenue Market Share by Countries (2012-2017)
Figure Africa Drugs for Schistosomiasis Revenue Market Share by Countries in 2012
Figure Africa Drugs for Schistosomiasis Revenue Market Share by Countries in 2016
Figure South Africa Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure Nigeria Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure Egypt Drugs for Schistosomiasis Sales and Growth (2012-2017)
Figure Algeria Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Middle East Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure Middle East Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure Middle East Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table Middle East Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure Middle East Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Figure Middle East Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017
Table Middle East Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Middle East Drugs for Schistosomiasis Sales Share by Type (2012-2017)
Table Middle East Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Middle East Drugs for Schistosomiasis Sales Share by Application (2012-2017)
Table EMEA Drugs for Schistosomiasis Sales by Type (2012-2017)
Table EMEA Drugs for Schistosomiasis Sales Share by Type (2012-2017)
Table EMEA Drugs for Schistosomiasis Revenue by Type (2012-2017)
Table EMEA Drugs for Schistosomiasis Revenue Share by Type (2012-2017)
Figure EMEA Praziquantel Sales Growth (2012-2017)
Figure EMEA Praziquantel Price (2012-2017)
Figure EMEA Oxamniquine Sales Growth (2012-2017)
Figure EMEA Oxamniquine Price (2012-2017)
Figure EMEA Other Sales Growth (2012-2017)
Figure EMEA Other Price (2012-2017)
Table EMEA Drugs for Schistosomiasis Sales by Application (2012-2017)
Table EMEA Drugs for Schistosomiasis Sales Share by Application (2012-2017)
Figure EMEA S. haematobium Sales Growth (2012-2017)
Figure EMEA S. mansoni Sales Growth (2012-2017)
Figure EMEA S. japonicum Sales Growth (2012-2017)
Figure EMEA S. mekongi Sales Growth (2012-2017)
Figure EMEA S. intercalatum Sales Growth (2012-2017)
Figure EMEA Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Drugs for Schistosomiasis Sales Forecast by Regions (2017-2022)
Table EMEA Drugs for Schistosomiasis Market Share Forecast by Regions (2017-2022)
Table Europe Drugs for Schistosomiasis Sales Forecast by Regions (2017-2022)
Figure Germany Drugs for Schistosomiasis Sales Forecast 2017-2022
Figure France Drugs for Schistosomiasis Sales Forecast 2017-2022
Figure UK Drugs for Schistosomiasis Sales Forecast 2017-2022
Figure Russia Drugs for Schistosomiasis Sales Forecast 2017-2022
Figure Italy Drugs for Schistosomiasis Sales Forecast 2017-2022
Figure Turkey Drugs for Schistosomiasis Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Drugs for Schistosomiasis Sales Forecast 2017-2022
Figure Israel Drugs for Schistosomiasis Sales Forecast 2017-2022
Figure UAE Drugs for Schistosomiasis Sales Forecast 2017-2022
Figure Iran Drugs for Schistosomiasis Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Drugs for Schistosomiasis Sales Forecast 2017-2022
Figure Nigeria Drugs for Schistosomiasis Sales Forecast 2017-2022
Figure Egypt Drugs for Schistosomiasis Sales Forecast 2017-2022
Figure Algeria Drugs for Schistosomiasis Sales Forecast 2017-2022
Table EMEA Drugs for Schistosomiasis Sales Forecast by Type (2017-2022)
Table EMEA Drugs for Schistosomiasis Market Share Forecast by Type (2017-2022)
Table EMEA Drugs for Schistosomiasis Sales Forecast by Application (2017-2022)
Table EMEA Drugs for Schistosomiasis Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List

More Publications

Need Help?

Ask a Question

Market Reports

All Categories